Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 1
Therapeutic Workplace Maintenance Study
2 other identifiers
interventional
51
1 country
1
Brief Summary
This application is a competing continuation of a grant in which we developed and pilot tested a computerized Therapeutic Workplace designed to train and employ adults as data entry operators. A randomized trial is planned over 5 years to investigate the Therapeutic Workplace business as a maintenance intervention to sustain long-term abstinence and employment. Welfare recipients in methadone treatment, actively using cocaine, and at risk for contracting or spreading HIV infection will participate in an initial Therapeutic Workplace training phase. Participants who become abstinent and skilled will be randomly assigned to an Abstinence \& Employment, or an Employment Only group. Participants in the Abstinence \& Employment group will be employed for one year in a Therapeutic Workplace business and will have to provide drug-free urine samples to work and earn salary. Employment Only participants will be offered employment for one year, but these participants will not have to provide drug-free urine samples to work. This study will provide a rigorous evaluation of the efficacy of the Therapeutic Workplace business as a long-term treatment of cocaine addiction and unemployment; determine the benefits of requiring daily evidence of abstinence to work; and provide information on the extent to which a Therapeutic Workplace business can become self-sustaining. This research could provide firm scientific foundation for the dissemination of Therapeutic Workplace businesses in the long-term treatment of cocaine addiction and unemployment. The main hypothesis being tested is that cocaine abstinence will be reliably maintained during the yearlong intervention evaluation period only in the group exposed to the explicit abstinence maintenance intervention. We expect that cocaine abstinence in the Abstinence and Employment group will be significantly greater than cocaine abstinence in the Employment Only group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2003
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2003
CompletedFirst Submitted
Initial submission to the registry
November 3, 2005
CompletedFirst Posted
Study publicly available on registry
November 7, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2007
CompletedResults Posted
Study results publicly available
December 16, 2016
CompletedSeptember 18, 2017
August 1, 2017
3.8 years
November 3, 2005
August 31, 2016
August 18, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of Monthly Urine Samples That Are Negative for Cocaine
The percentage of urine samples collected at monthly assessments that are negative for cocaine.
1 year
Secondary Outcomes (4)
Percentage of Monday, Wednesday and Friday Urine Samples That Are Negative for Cocaine
1 year
Percentage of 30-day Assessment Urine Samples Negative for Opiates
1 year
Percentage of Monday, Wednesday and Friday Urine Samples That Are Negative for Opiates
1 year
HIV Risk Behaviors
1 year
Study Arms (2)
Employment Only
ACTIVE COMPARATOREmployment Only participants will be offered employment for one year, but these participants will not have to provide drug-free urine samples to work.
Contingency Management
EXPERIMENTALParticipants in the Contingency Management group will be employed for one year in a Therapeutic Workplace business and will have to provide drug-free urine samples to work and earn salary.
Interventions
Participants in the Contingency Management group will be employed for one year in a Therapeutic Workplace business and will have to provide drug-free urine samples to work and earn salary.
Employment Only participants will be offered employment for one year, but these participants will not have to provide drug-free urine samples to work.
Eligibility Criteria
You may qualify if:
- Applicants in methadone treatment may be eligible to participate in Phase 1 of the study.
- Applicants will be blind to the full details of the eligibility criteria.
- Unemployed
- Provided a urine sample at intake with a detectable concentration of cocaine metabolite or provided a cocaine positive sample during regular urinalysis testing at a methadone maintenance program
- Met DSM-IV criteria for cocaine dependence
- Were receiving welfare benefits in Baltimore, MD
- Received a score of less than or equal to 80% correct on a reading assessment
You may not qualify if:
- Being at imminent risk for suicide
- Reported hallucinations
- Being incarcerated or otherwise under constant monitoring
- Earned less than or equal to $200 in unreported taxable income from legal activity in the previous month
- Having physical limitations that prevented typing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Universitylead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
The Center for Learning and Health
Baltimore, Maryland, 21224, United States
Related Publications (2)
DeFulio A, Donlin WD, Wong CJ, Silverman K. Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: a randomized controlled trial. Addiction. 2009 Sep;104(9):1530-8. doi: 10.1111/j.1360-0443.2009.02657.x.
PMID: 19686522RESULTDeFulio A, Silverman K. Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: post-intervention outcomes. Addiction. 2011 May;106(5):960-7. doi: 10.1111/j.1360-0443.2011.03364.x. Epub 2011 Mar 7.
PMID: 21226886DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Kenneth Silverman
- Organization
- Johns Hopkins School of Medicine: Department of Psychiatry
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth Silverman, Ph.D.
Johns Hopkins University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2005
First Posted
November 7, 2005
Study Start
October 1, 2003
Primary Completion
August 1, 2007
Study Completion
August 1, 2007
Last Updated
September 18, 2017
Results First Posted
December 16, 2016
Record last verified: 2017-08
Data Sharing
- IPD Sharing
- Will not share
The results were published in a peer-reviewed journal.